Treatment News

Scientists at Yale School of Medicine design a virus to treat ovarian cancer A new Yale study showed that certain genetically modified viruses can cure ovarian cancer in mice. It may be of use in the treatment of ovarian cancer in humans. Researchers at the Yale...

Surgical treatment of ovarian cancer during the COVID 19 pandemic Ovarian cancer patients may be at greater risk during the pandemic Surgery can be done safely, but doctors may recommend postponement and using chemotherapy first, depending on local COVID-19 conditions...

PARP inhibitors have shown significant promise in the treatment of ovarian cancer. Olaparib is a PARP inhibitor that has been approved for maintenance for BRCA-mutated ovarian cancer in the recurrent and front-line setting as well as for treatment of BRCA-mutated...

For the past few years, as part of the University of Chicago Pritzker medical school obstetrics-gynecology rotation, med students at an optional lunchtime seminar hear from ovarian cancer survivors who share stories about the shock of diagnosis, painful treatments and...